Active ingredientAliskiren HemifumarateCat. No. P-A077-001Family · Pharmaceutical analytical standards
Aliskiren
The first drug in the class of direct renin inhibitors, which block the enzyme that starts the hormonal cascade through which the kidney regulates blood pressure. Designed with the help of crystallography and molecular modelling, it was approved in 2007 in the US and Europe for hypertension. This family brings together the active ingredient and other impurities.
Did you know?Its target had been known for over a century: in the late 19th century Robert Tigerstedt and Per Bergman saw that kidney extracts injected into rabbits raised blood pressure, and named the active substance renin.
Go to the active ingredient →Active ingredientAliskiren HemifumarateCat. No. P-A077-001
ImpurityAliskiren Amino Lactone ImpurityCat. No. P-A077-004
ImpurityAliskiren Hemifumarate (SSSR isomer) ImpurityCat. No. P-A077-007
ImpurityAliskiren Impurity 1Cat. No. P-A077-009
ImpurityAliskiren Michael Adduct-1 ImpurityCat. No. P-A077-010
ImpurityAliskiren Michael Adduct-2 ImpurityCat. No. P-A077-011
ImpurityN-Boc AliskirenCat. No. P-A077-014CAS 173338-07-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.